Vertex Pharmaceuticals Corporation
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Investors
%20.jpg)
Connections from
Funding Status:
IPO
Industry:
Pharma
Estimated Revenue:
$500M to $1B
Technology:
Cancer
Acquisitions Number:
Made Acquisitions
Number Of Exists:
2
Headquarters:
Boston, Massachusetts, United States
Total Funding:
656200000.0
Last Funding Date:
2022-05-17
Last Funding Type:
Post-IPO Equity
Investor Type:
Company
Employee Number:
1001-5000
Investors Number:
9.0
Investment Stage:
N/A
Founded Date:
1989-01-01